Journal article
Positioning As-needed Budesonide–Formoterol for Mild Asthma: Effect of Prestudy Treatment in Pooled Analysis of SYGMA 1 and 2
Abstract
Rationale: The SYGMA (Symbicort Given as Needed in Mild Asthma) studies evaluated the efficacy and safety of as-needed budesonide (BUD)-formoterol (FORM) in patients whose asthma was uncontrolled on as-needed inhaled short-acting bronchodilators (subgroup 1) or controlled on inhaled corticosteroids (ICS) or leukotriene receptor antagonists (subgroup 2). Objectives: To assess the influence of prestudy treatment in a post hoc analysis of the …
Authors
Bateman ED; O’Byrne PM; FitzGerald JM; Barnes PJ; Zheng J; Lamarca R; Puu M; Parikh H; Alagappan V; Reddel HK
Journal
Annals of the American Thoracic Society, Vol. 18, No. 12, pp. 2007–2017
Publisher
American Thoracic Society
Publication Date
December 2021
DOI
10.1513/annalsats.202011-1386oc
ISSN
2329-6933